Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517640 | SCV000612575 | benign | not specified | 2016-12-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000831711 | SCV000973464 | likely benign | not provided | 2021-04-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001088434 | SCV001095451 | benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000831711 | SCV001501691 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | CACNA1A: BP4, BP7 |
Ambry Genetics | RCV002448557 | SCV002682994 | likely benign | Inborn genetic diseases | 2018-02-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000517640 | SCV005204245 | likely benign | not specified | 2024-06-14 | criteria provided, single submitter | clinical testing |